swainsonine is a specific and potent inhibitor of alpha-mannosidase ( ec 3.2.1.24 ) and when administered to animals produces a phenocopy of the genetically based lysosomal storage disease , mannosidosis .
C0085078
lysosomal storage disease
C1257960
mannosidosis